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Article Information  ABSTRACT 
Received: 10th February 2018  Purpose: Natural remedies from medicinal plants are considered to be effective and safe 
alternative treatments for diabetes mellitus. Diodia sarmentosa (Rubiaceae) commonly called 
tropical button weed, has been used locally in the treatment of diabetes. This study demonstrates 
the hypoglycaemic and anti-diabetic activity of the aqueous ethanol extract and ethylacetate 
fractions of Diodia sarmentosa in alloxan-induced diabetic rats. Methods: 1000g of the leaves 
(air dried at 250C for 7days) was subjected to extraction using 80% aqueous ethanol and then 
fractionated with ethylacetate. This gave a percentage yield of 13.299%w/w, 28.30%w/w, and 
11.62%w/w for aqueous ethanol extract, ethylacetate soluble and insoluble fraction respectively. 
Three doses (1000mg/kg, 500mg/kg and 250mg/kg body weight) of the three samples were 
administered to the test groups while Glibenclamide at dose of 2.5mg/kg body weight was 
administered to the control group. Comparing the activity of the plant to the standard drug, the 
activity of all the doses of the aqueous ethanol extract and ethylacetate insoluble fraction was 
comparable with that of the standard drug (Glibenclamide). Result: As regard to the dose 
response, the highest activity resides in the highest dose of sample administered (i.e 1000mg/kg 
body weight) followed by the 500mg/kg and the 250mg/kg body weight 
(1000mg/kg>500mg/kg>250mg/kg). The aqueous ethanol and ethylacetate soluble fractions 
caused a significant (p>0.05) reduction in blood glucose of the diabetic rats. Conclusion: Thus, 
this present study validates the medicinal potential of Diodia sarmentosa in diabetes treatment. 
 
Revised: 17th March 2018 
Accepted: 28th March 2018 
   
Keywords 
Diodia sarmentosa, diabetes mellitus, 
rats, alloxan, glibenclamide  
 
_______________________________________________________________________________________________ 
1 University of Port Harcourt, Port Harcourt, Nigeria 
2 Dept of Chemical Pathology, University of Calabar Teaching Hospital, Calabar, Nigeria 
 
Journal of Applied Pharmaceutical Research 6 (1); 2018: 26 – 32  Ekpe et. al  
 
 
  Journal of Applied Pharmaceutical Research (JOAPR) | January – March 2018 | Volume 6 Issue 1 | 27 
INTRODUCTION 
Diabetes mellitus is a disorder of carbohydrate, fat and protein 
metabolism with elevations in fasting and postprandial blood 
glucose and a significant increased risk of various organ 
problems, atherosclerosis, nerve dysfunction and stroke [1].  It 
is the most common endocrine disorder affecting more than 
300million people worldwide [2]. It is ranked among the 
leading causes of death especially when all its fatal 
complication are taken into account [3]. Diabetes mellitus is  a 
major health problem with increasing prevalence all over the 
world. This is evident in the projection by the WHO that by 
2030, diabetes mellitus will become the seventh leading cause 
of death in the world [4]. Worldwide prevalence of diabetes for 
all age groups was estimated to be 2.8% in 2000 and it is 
projected to be 5.4% in 2025 and has been associated with 
sedentary lifestyle [5]. The global prevalence of type 2 diabetes 
is estimated to reach 4.4% by 2030. Among the various type of 
diabetes mellitus, type 1 diabetes account for about 5-10% of 
diabetics diagnosis, while type 2 account for 90% [6].Total 
number of patients with type 2 diabetes will reach 366 million 
in 2030 [7, 8]. 
 
According to the 2004 estimates, the Diabetes Association of 
Nigeria (DAN) puts the diabetics’ population in Nigeria at 
about 10 million and about half of this number is in Lagos state 
because of its very cosmopolitan nature. In a separate study by 
Akinkugbe  et al, crude prevalence rate of 7.2% was reported 
for the Lagos mainland (one of the LGA’s in the present 
survey) in a national non-communicable disease survey [9]. 
Blood glucose level is normally maintained in a very narrow 
range, usually 70 to 120 mg/dL [10]. Globally, herbal medicine 
has been used extensively in the treatment of diabetes and other 
diseases that constitute growing health problems among 
residents in Nigeria especially the less privileged ones who 
cannot afford orthodox medicine. This situation is further 
complicated by the fact that most antidiabetic drugs in use 
today present with serious side effects that have placed 
limitations to their usage. This study is thus designed to 
scientifically establish the antidiabetic activity of D. 
sarmentosa and to justify the use of the plant by traditional 
practitioners for the treatment of diabetes mellitus and also to 
determine the toxicity profile of the plant.    Management of 
this disorder involves lifestyle changes, proper dieting, exercise 
and administration of insulin preparations or hypoglycaemic 
medications [11]. Although, oral hypoglycaemic agents and 
insulin are cornerstones in the treatment of various types of 
diabetes, their uses are limited by high cost, low efficacy, 
associated side effects, failure to prevent the long-term 
complications thus leading to non-compliance to therapy and 
ultimately treatment failure [12]. Hence, the management of the 
disease remains a major health care challenge in Nigeria and 
other developing countries. This has prompted researchers 
globally to explore and assess new methods and more 
appropriate ways to control the disease and its complications12. 
Treating diabetes with plant-derived compounds which are 
accessible and do not require laborious pharmaceutical 
synthesis seems highly attractive and potentially rewarding. 
The increasing public demand for natural products possessing 
anti-diabetic activity with fewer side effects has led the 
pharmaceutical industries and academic researches to pay more 
attention to medicinal plants [13]. Over the years, a number of 
successes have been recorded in the treatment of diabetes using 
herbs by local medical practitioners in Nigeria and globally. 
One example of such is metformin (biguanide) is traced to 
Galega officinalis [14, 15]. This study is therefore aimed at 
evaluating the antidiabetic activity of ethanol extract and 
ethylacetate fractions of the leaf of Diodia sarmentosa in 
alloxan-induced diabetic rat model. 
 
MATERIALS & METHODS 
Fresh leaves of Diodia sarmentosa (Rubiaceae) were collected 
from farm areas in Ozoro, Isoko North LGA of Delta State 
Nigeria in April 2013. The fresh leaves were identified and 
authenticated by a botanist. Adult Wister albino rats (4-6 
months old) of both sexes weighing 250-350g were obtained 
for this study. The animals were housed in metallic cages, 
acclamatized for two weeks under standard environmental 
conditions and maintained on a regular feed  and water ad 
libitum before being employed for experiment. Fresh leaves of 
plant were collected and dried at room temperature (25±2oC) 
for seven days. The dried powdered leaves of Diodia 
sarmentosa (1000 g) was extracted by maceration in 80% 
ethanol. The extracting vessel was shaken intermittently before 
being kept in a cool cupboard overnight. The solvent was 
filtered every day and replaced with fresh 80% ethanol. The 
extracts were first filtered with a white muslin cloth after which 
the filtrates were refiltered using a Whatman no 1 filter paper 
and suction pump (Buckner funnel). The resultant extract was 
weighed and stored in a clean sample bottle in a desiccator 
until required for analysis [16]. From the crude 80% aqueous 
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ethanol extract, 50 g was fractionated using ethyl acetate to 
obtain soluble and insoluble fractions of ethylacetate according  
with slight modification as done by other researchers [17–20]. 
The ethyl acetate fractions were concentrated in vacuum using 
a rotary evaporator to obtain a semi-solid mass. The 
concentrated ethylacetate fractions were then evaporated to 
dryness in a water bath at 40-45°C. The resultant extract was 
weighed and stored in a clean sample bottle in a desiccator 
until when required for analysis. The various extract yields 
were determined. 
 
The animals were fasted overnight for 12 hours but allowed 
free access to water. Initial blood glucose level (zero time) was 
determined before assay using glucometer/strips (accuchek) as 
described by Saleem et al [21]. Rats in groups 1-3 were made 
hyperglycaemic by oral administration of 4g/kg glucose 
solution. Rats in group 4 were not glucose loaded or treated 
with extract. Extract of D. sarmentosa (1000mg/kg) was 
administered orally to animals in group 1 while glibenclamide 
(2.5mg/kg) was administered to group 2. Group 3 served as 
hyperglycaemic untreated control. Blood glucose was 
determined 30minutes after treatment and continued every 
30minutes for three hours [16]. 
 
Alloxan-induced diabetic test 
Induction of diabetes and grouping of diabetic rats 
Animals were divided into 13 groups of 4 animals each. 12 
groups were made to fast overnight and made diabetic by a 
single intraperitoneal injection of alloxan monohydrate 
(180mg/kg) dissolved in normal saline [22]. The animals 
turned diabetic within 7 days. Animals with blood glucose level 
≥200mg/dl was considered to be diabetic and used for this 
study.  
 
Statistical Analysis 
Data from the study was statistically evaluated using one way 
Analysis of Variance (ANOVA) followed by Bonferroni 
posthoc test in statistical package for social sciences (SPSS 
version 20.0) to compare the equality of two or more 
independent groups of treated means with 5% level of 
significance. The test of significance may be taken as 
procedures that enable us to accept or reject hypothesis or to 
determine if observed samples differ significantly from 
expected results. Besides, the results are expressed as mean ± 
SD.  P<0.05 was considered statistically significant. 
RESULT  
Phytochemical screening 
The results of the preliminary phytochemical analysis of the 
leaf extract of Diodia sarmentosa revealed the presence of 
flavonoids, saponins, tannins, steroids and glycoside. 
 
Acute toxicity studies 
The LD50 of ethanol extract of Diodia sarmentosa in Wistar 
rats of both sex was found to be above 5000mg/kg body weight 
orally. 
 
Table 1: Percentage yield of extract and fractions 
Extract % yield (%w/w) 
80% aqueous ethanol extract 13.3 
Ethylacetate insoluble fraction 65.3 
Ethylacetate soluble fraction 14.9 
 
DISCUSSION 
The present study investigated the phytochemical, 
pharmacological, and anti-diabetic activities of the leaves of 
Diodia sarmentosa. The aqueous ethanol leaf extracts of 
Diodia sarmentosa was obtained by cold maceration of 1000g 
of the starting material for 96 hours (4 days). The percentage 
yield of ethanol extract, ethylacetate insoluble and ethylacetate 
soluble fraction of the plant were calculated to be 13.29% w/w, 
65.28% w/w and 14.9% w/w respectively. The phytochemicals 
of medicinal importance detected in the crude powder leaves of 
the plants, aqueous ethanol extract, ethyl acetate soluble 
fraction and insoluble fraction as presented in the results are 
saponins, flavonoids, steroids, glycosides and tannins, while 
alkaloids, phlobatannins, cyanogenetic glycosides and 
anthraquinones were not detected. Flavonoids and tannins are 
phenolic compounds. Plant phenolics have been found to be a 
major group of compounds that act primarily as antioxidants or 
free radical scavengers [23]. Evaluating the hypoglycaemic 
activity of the plant in alloxan-induced diabetic rats; the  
aqueous ethanol extract and ethyl acetate insoluble fractions of 
D. sarmentosa at various doses of 250, 500 & 1000 mg/kg 
body weight and also the standard drug (glibenclamide, 2.5 
mg/kg b.w) caused a significant decrease (p<0.05) in the blood 
glucose level of the diabetic rats. During the oral glucose 
tolerance test, it was found that the the postpandrial blood 
glucose levels of the rats increased to the peak at 30 minutes 
after oral administration of glucose. Treatment with ethanol 
extract (1000 mg/kg) produced a significant (P<0.05) 
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hypoglycaemic effect (24.66%) in glucose loaded rats at 
60minutes. The ethanol extract evoked a progressive decrease 
in blood glucose level up to 210 minutes. Result showed that 
glibenclamide also evolved a significant (P<0.05) suppression 
of blood glucose occurring from 1hour at 22.06%. The 
pronounced effect being recorded was at 210 minutes with 
35.69% and 43.62% for aqueous ethanol extract and 
glibenclamide respectively.  
 
From the results obtain, it could further be deduced that the 
anti-diabetic activity of the 80% aqueous ethanol extract and 
ethylacetate insoluble fraction at all doses were comparable 
with that of the standard drug, glibenclamide. Significant 
decrease was seen from day 3 in the group treated with ethanol 
and ethylacetate insoluble fraction and to almost normal by day 
7 when compared to diabetic untreated control. In the 
ethylacetate soluble fraction, reduction of blood glucose in 
diabetic rat was not statistically significant (p<0.05) when 
compared to diabetic untreated values. Maximum activity was 
on day 6 fasting blood glucose at 80.04% for glibenclamide 
and 86.13% for 500 mg/kg aqueous ethanol extract group on 
day 8 of sacrifice (see Table1, 2, 3 and 4). 
Tannins and saponins are also found to be effective 
antioxidants, antimicrobial, and anti-carcinogenic agents [24]. 
These activities are thought to be primarily due to the anti-
oxidant activity of flavonoids. Furthermore, phytochemicals 
such as saponins, terpenoids, flavonoids and tannins are found 
to inhibit cancer cell proliferation, regulate inflammatory and 
immune response as well as protect against lipid peroxidation 
[23]. Some of these potential health benefits of polyphenolic 
substances have been related to the action of these compounds 
as antioxidants, free radical scavengers, quenchers of singlet 
and triplet oxygen and inhibitors of peroxidation [25]. This 
result suggests that the leaves of the plants relatively regulate 
inflammatory and immune response as well as protect against 
lipid peroxidation and complications [23]. 
 
Anti-diabetic Study 
Table 2: Effect of fractions of Diodia sarmentosa and Glibenclamide on blood glucose of alloxan-induced diabetic rats in day 1 of 
treatment.  
Treatment 
Dose 
(mg/kg b.w) 
Daily blood glucose level 
0HR 1HR 2HR 3HR 
Diabetic treated 
with ethylacetate 
Insoluble fraction 
1000 356.80±64.95 (11.11)* 295.00±85.68 (35.02)* 439.40±35.32 (11.69) 437.20±33.51 (17.02) 
500 401.40±53.92 (20.25) 454.00±92.25(10.41) 393.40±67.50(31.07)* 373.60±33.38(30.45)* 
250 336.60±40.18(33.12) * 586.00±9.62(15.64) 486.00±11.60(14.84) 493.60±74.34(8.10) 
Diabetic treated 
with Ethylacetate 
soluble fraction 
1000 355.40±54.13(19.02) 270.60±59.58(0.00) 297.00±46.09(4.21) 292.40±23.37(19.74) 
500 
265.60±43.56 
(11.05) 
201.00±57.43 
(25.72) 
250.00±29.03 
(12.28) 
236.00±20.62 
(3.36 
250 
207.00±8.46 
(30.68) 
184.60±62.04 
(31.78) 
190.20±51.32 
(33.26) 
179.40±49.32 
(26.54) 
Diabetic treated 
with Glibenclamide 
2.5 ml/kg 
596.60±5.27 
(18.54) 
536.80±54.13 
(5.93) 
469.60±77.79 
(17.72) 
447.00±74.98 
(16.78) 
Diabetic untreated 
administered DMSO 
3 ml/kg 503.30±18.99 506.75±10.09 570.70±21.69 537.13±97.42 
Diabetic Untreated 
administered olive 
oil control 
3 ml/kg 298.60±170.96 270.60±130.87 285.00±157.68 244.20±40.42 
Normal   77.20±0.84 84.00±1.58 70.20±6.06 83.60±2.70 
Values are mean ±SD; n= 5; figures in parenthesis indicate % decrease in blood glucose. Superscripted items (*) indicate 
significant different from control at P< 0.05.  
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Table 3: Hypoglycaemic effects of fractions of Diodia sarmentosa on post-treatment blood glucose(mg/dl) of diabetic rats from 
days 2-7 of treatment. 
Treatment 
Dose 
(mg/kg) 
Daily Post- Daily blood glucose level blood glucose 
DAY 2 DAY 3 DAY 4 DAY 5 DAY 6 DAY 7 
Diabetic treated with 
ethylacetate 
Insoluble fraction  
fraction 
1000 
490.40±81 
(14.17) 
403.40±12 
(31.14) * 
497.60±69.31 
(2.39) 
340.20±20.54 
(40.65) * 
253.20±41.4 
(57.33) * 
227.60±26. 
(61.20) * 
500 
544.60±53. 
(4.68) 
518.40±33 
(11.51) 
488.00±29.83 
(4.28) 
356.80±55.26 
(38.04) * 
303.20±20.9 
(48.90) * 
247.80±54. 
(57.76) * 
250 
494.80±74. 
(13.40) 
496.40±74 
(15.26) 
262.80±1.30 
(48.45) * 
399.20±23.40 
(30.68) 
270.75±23.3 
(54.37) * 
255.50±41. 
(56.45) * 
Diabetic treated with 
ethylacetate soluble 
fraction  
1000 
515.40±56. 
(7.97) 
494.20±37. 
(2.75) 
515.20±3.35 
(35.44) 
511.20±48.19 
(14.37) 
466.80±8.90 
(33.6) 
463.60±33. 
(19.95) 
500 
440.00±64. 
(21.43) 
446.20±29 
(12.20) 
466.80±3.96 
(22.71) 
352.40±74.61 
(40.97)* 
272.40±57.6 
(22.04) 
335.20±51. 
(42.13)* 
250 
577.20±44. 
(3.07) 
502.40±57. 
(1.14) 
497.40±63.97 
(30.76) 
445.40±60.83 
(25.39) 
467.40±81.6 
(33.77) 
427.60±69. 
(26.17) 
Diabetic untreated 
administered DMSO 
3ml/kg 571.33±19. 585.80±11. 509.80±44.25 575.87±19.53 593.40±4.16 575.87±19. 
Diabetic Untreated 
with oil control 
3ml/kg 560.00±38. 508.20±60. 380.50±216.6 597.00±2.45 349.67±215. 597.00±2.4 
Values are mean ±SD; n= 5; figures in parenthesis indicate % decrease in blood glucose. Superscripted items (*) indicate 
significant different from control at P< 0.05. 
 
Table 4: Effect of fractions of D. sarmentosa  and glibenclamide on fasting blood glucose(mg/dl) of alloxan-induced diabetic rats. 
Values are mean ±SD; n= 5; figures in parenthesis indicate % decrease in blood glucose. Superscripted items (*) indicate 
significant different from control at P< 0.05. 
 
 
Treatment 
Fasting blood glucose 
Dose 
(mg/kg) 
DAY 4 DAY 6 DAY 8 
Diabetic treated with 
ethylacetate Insoluble fraction 
1000 70.80±7.46 (38.44)* 53.80±2.49 (27.79)* 50.40±0.89 (20.09)* 
500 88.60±8.08 (81.27)* 87.40±22.61 (85.55)* 69.80±14.52 (82.41)* 
250 107.80±23.82 (60.48)* 184.40±35.75 (65.34)* 167.40±16.35 (78.60)* 
Diabetic treated with 
Ethylacetate soluble fraction 
1000 241.20±47.92 (49.42) 139.20±15.34 (3.69)* 275.60±88.83 (21.17)* 
500 188.80±54.64 (38.30)* 293.40±68.10 (6.61) 270.40±28.91 (1.73)* 
250 307.20±67.07 (14.89) 248.00±49.05 (8.50) 288.40±47.13 (9.88)* 
Diabetic treated with 
Glibenclamide 
2.5mg/kg 162.80±3.90 (67.69) 82.80±40.12 (82.26)* 96.40±22.68 (80.04)* 
Diabetic untreated 
administered DMSO  
571.33±19.61 585.80±11.10 509.80±44.25 
Diabetic Untreated 
administered olive oil control 
3ml/kg 306.0±157.7 275.25±103.15 265.75±123.62 
Normal  74.20±0.84 81.00±1.58 80.20±6.06 
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Oral glucose tolerance test 
Table 5: Effects of aqueous ethanol extract (1000mg/kg) of Diodia sarmentosa and glibenclamide on blood glucose (mg/dl)  level 
of glucose loaded rats. 
  
Blood Glucose level (mg/dl) 
 
 
0 hr 30min 60min 90min 120min 150min 180min 210min 240min 
Hyperglycaemic rats 
(treated with extract 
1g/kg) 
98.20 
±16.04 
(0.89) 
123.80 
±17.85 
(16.54) 
110.00 
±13.69 
(24.66)* 
102.40 
±15.69 
(26.51)* 
97.40 
±15.90 
(28.91) 
91.80 
±19.64 
(29.75)* 
83.00 
±13.27 
(27.41)* 
74.60 
±6.43 
(35.69)* 
69.60 
±11.28 
(31.09) 
Normal rats(mg/dL) 
74.80 
±15.47 
77.20 
±7.98 
74.80 
±12.34 
72.60 
±6.80 
75.40 
±13.52 
72.40 
±8.08 
68.40 
±4.16 
66.40 
±3.44 
67.40 
±3.97 
Hyperglycaemic  rats 
(treated with 
glibenclamide 2.5mg/ 
kg)  
92.00 
±6.04 
(5.48) 
140.80 
±23.30 
(5.08) 
113.80 
±16.35 
(22.06)* 
111.00 
±7.78 
(20.34)* 
119.20 
±13.65 
(12.99) 
87.20 
±3.96 
(33.27)* 
78.40 
±6.88 
(31.43)* 
65.40 
±7.92 
(43.62)* 
68.80 
±4.76 
(31.88) 
Hyperglycaemic 
(untreated, control) 
97.33 
±4.73 
148.33 
±9.02 
146.00 
±6.56 
139.33 
±15.95 
137.00 
±10.39 
130.67 
±9.45 
114.33 
±21.36 
116.00 
±7.00 
101.0 
±4.00 
Values are mean ±SD; n= 5; figures in parenthesis indicate % decrease in blood glucose. Superscripted items (*) indicate 
significant different from control at P< 0.05 
 
CONCLUSION 
This works assess the efficacy and usefulness of Didia 
sarmentosa  as anti-diabetic agent, which if explored further 
would be highly beneficial in the pharmaceutical world as its 
extracts have a promising outcome in reducing plasma glucose. 
Its investigates the anti-diabetic property of the leaves of 
Diodia sarmentosa. With the successful induction of insulin 
dependent diabetes in albino rats, the leaves of the plants were 
found to reduce significantly both fasting and post-treatment 
blood glucose levels and mechanism of reduction in blood 
glucose maybe due to its ability to restore damaged beta cells 
of islet. The antidiabetic activity of the plant was resident in the 
80% aqueous ethanol extract and ethylacetate insoluble 
fraction. Comparing the activity of the plant to the standard 
drug, the plant was about the same efficacy as the standard 
drug when used under the same conditions. 
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